These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21646742)

  • 81. A Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKD.
    Nowak KL; Kakkar R; Devalaraja M; Lo L; Park W; Gobburu J; Kling D; Davidson M; Chonchol M
    Kidney360; 2021 Feb; 2(2):224-235. PubMed ID: 35373026
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Factors Predisposing to Hypertension in Subjects Formerly Born Preterm: Renal Impairment, Arterial Stiffness, Endothelial Dysfunction or Something Else?
    Crisafulli A; Bassareo PP; Kelleher S; Calcaterra G; Mercuro G
    Curr Hypertens Rev; 2020; 16(2):82-90. PubMed ID: 31244440
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
    Gregg LP; Tio MC; Li X; Adams-Huet B; de Lemos JA; Hedayati SS
    Am J Nephrol; 2018; 47(6):395-405. PubMed ID: 29874658
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients.
    Tsai YC; Hung CC; Kuo MC; Tsai JC; Yeh SM; Hwang SJ; Chiu YW; Kuo HT; Chang JM; Chen HC
    PLoS One; 2012; 7(12):e52775. PubMed ID: 23300770
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The association between food insecurity and inflammation in the US adult population.
    Gowda C; Hadley C; Aiello AE
    Am J Public Health; 2012 Aug; 102(8):1579-86. PubMed ID: 22698057
    [TBL] [Abstract][Full Text] [Related]  

  • 86. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
    Fu EL; Franko MA; Obergfell A; Dekker FW; Gabrielsen A; Jernberg T; Carrero JJ
    Am Heart J; 2019 Oct; 216():20-29. PubMed ID: 31382219
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
    Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
    Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.
    Skali H; Uno H; Levey AS; Inker LA; Pfeffer MA; Solomon SD
    Am Heart J; 2011 Sep; 162(3):548-54. PubMed ID: 21884875
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
    Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.
    Li WJ; Chen XM; Nie XY; Zhang J; Cheng YJ; Lin XX; Wu SH
    Clinics (Sao Paulo); 2015 Apr; 70(4):301-11. PubMed ID: 26017799
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Serum C-reactive protein levels and death and cardiovascular events in mild to moderate chronic kidney disease.
    Koeda Y; Nakamura M; Tanaka F; Onoda T; Itai K; Tanno K; Ohsawa M; Makita S; Ishibashi Y; Koyama T; Yoshida Y; Omama S; Ogasawara K; Ogawa A; Kuribayashi T; Okayama A
    Int Heart J; 2011; 52(3):180-4. PubMed ID: 21646742
    [TBL] [Abstract][Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.